Methdilazine Hcl
Drug - Methdilazine Hcl
The trade name of the product as shown on the labeling.
Dosage -
SYRUP; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Methdilazine Hydrochloride
Multiple ingredients are in alphabetical order.
Strength -
4MG/5ML
The potency of the active ingredient(s), Methdilazine Hydrochloride. May repeat for multiple part products.
Applicant -
ALPHARMA US PHARMS
The firm name holding legal responsibility for Methdilazine Hcl. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
087122
The FDA assigned number to Methdilazine Hcl. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Methdilazine Hcl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Methdilazine Hcl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Methdilazine Hcl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Methdilazine Hcl is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Alpharma Us Pharmaceuticals Division
The full name of the firm holding legal responsibility for the new application of Methdilazine Hcl.
Methdilazine Hcl
|
